Of course these figures I mention are for when we establish good revenue streams. Before that anything is possible. PNV as an example reached about a 1.5 billion market cap with revenue of only 9 million and no profit. So really any wild guess could be as accurate as the best business model predictions with the way these early stage medical companies can be valued.
Paradigm SP End of Year Predictions, page-58
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.86M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.5¢ | $73.23K | 328.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 91337 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 101856 | 6 |
View Market Depth
| Last trade - 14.20pm 11/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |